Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Database and Biobank of Patients With Gynecologic Neoplasms

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2010 by Huazhong University of Science and Technology.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
Zhejiang University
Hunan Province Tumor Hospital
Guangxi Medical University
Health Science Center of Xi’an Jiaotong University
Information provided by:
Huazhong University of Science and Technology
ClinicalTrials.gov Identifier:
NCT01267851
First received: December 28, 2010
Last updated: February 14, 2011
Last verified: December 2010
  Purpose
The database and biobank establishment started in 1997 in our institute. However, the sample size was too small with respect to our clinical and fundamental scientific research's requirement. Thus the Chinese gynecological oncology study (GOS) group was established to create a large multicentre database and biobank of patients with gynecologic diseases.

Condition
Cervical Cancer
Ovarian Cancer
Endometrial Cancer
Choriocarcinoma
Uterine Fibroids
Endometriosis

Study Type: Observational
Official Title: A Large Multicentre Clinical Database and Biobank of Patients With Gynecologic Neoplasms

Resource links provided by NLM:


Further study details as provided by Huazhong University of Science and Technology:

Study Start Date: January 1999
Detailed Description:

The database contains clinical and epidemiologic information about patients with gynecologic neoplasms, such as cervical carcinoma, ovarian carcinoma, etc. With the data gathered from this database, the investigators could further demonstrate the etiology, risk factor, clinical treatment, and other aspects of the complicated gynecologic diseases. The cervical cancer database v1.10 including more than 10,000 cases and more than 200 variables has been established.

The biobank collects blood, fluids, tissue samples, and related clinical data from consenting patients with gynecologic neoplasms, such as cervical cancer, ovarian cancer, endometrial cancer, choriocarcinoma, uterine myoma, endometriosis. Besides, blood samples of population-based healthy people with informed consent are also collected.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
gynecologic diseases, such as cervical cancer, ovarian cancer, endometrial cancer, choriocarcinoma, uterine myoma, endometriosis, as well as part of population-based healthy women
Criteria

Inclusion Criteria:

  • patients with informed consent;
  • patients with gynecologic diseases;
  • patients with intact clinical and pathological information

Exclusion Criteria:

  • not included in the inclusion criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01267851

Locations
China, Hubei
Tongji Hospital of HUST
Wuhan, Hubei, China
Sponsors and Collaborators
Huazhong University of Science and Technology
Zhejiang University
Hunan Province Tumor Hospital
Guangxi Medical University
Health Science Center of Xi’an Jiaotong University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Ding Ma, Cancer Biology Research Center of Tongji Hospital
ClinicalTrials.gov Identifier: NCT01267851     History of Changes
Other Study ID Numbers: GM2010-06-02 
Study First Received: December 28, 2010
Last Updated: February 14, 2011
Health Authority: China: Ministry of Health

Keywords provided by Huazhong University of Science and Technology:
gynecologic disease

Additional relevant MeSH terms:
Neoplasms
Uterine Cervical Neoplasms
Endometrial Neoplasms
Endometriosis
Leiomyoma
Myofibroma
Choriocarcinoma
Genital Neoplasms, Female
Uterine Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female
Neoplasms, Muscle Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms, Connective Tissue
Connective Tissue Diseases
Trophoblastic Neoplasms
Neoplasms, Germ Cell and Embryonal
Adenocarcinoma
Carcinoma
Neoplasms, Glandular and Epithelial
Pregnancy Complications, Neoplastic
Pregnancy Complications

ClinicalTrials.gov processed this record on December 09, 2016